Cytokinetics Inc

CYTK:NASDAQ
RT Quote | NASDAQ | USD
Last | 01/27/21 EST
20.25quote price arrow down-0.04 (-0.20%)
Volume
867,561
52 week range
8.00 - 30.14

...

Loading . . .

KEY STATS

  • Open20.10
  • Day High20.57
  • Day Low19.35
  • Prev Close20.25
  • 52 Week High30.14
  • 52 Week High Date10/05/20
  • 52 Week Low8.00
  • 52 Week Low Date03/18/20
  • Market Cap1,433.29M
  • Shares Out70.78M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • 1 Year % Change68.33

RATIOS/PROFITABILITY

  • EPS (TTM)-1.91
  • P/E (TTM)-10.58
  • Fwd P/E (NTM)-11.28
  • EBITDA (MRQ)-79.48M
  • ROE (MRQ)-175.74%
  • Revenue (MRQ)54.32M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-209.88%
  • Debt To Equity (MRQ)89.58%

EVENTS

  • Earnings Date03/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Cytokinetics Inc News

There is no recent news for this security.

Latest CYTK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development of small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. The Company is developing small...
Leonard Patrick Gage Ph.D.
Chairman
Robert Blum
Chief Executive Officer
Ching Jaw
Chief Financial Officer
Robert Wong
Chief Accounting Officer
Fady Malik M.D., Ph.D.
Executive Vice President
Address
280 E Grand Ave
South San Francisco, CA
94080-4808
United States